## Comprehensive characterization of protein-protein interaction network perturbations by human disease mutations

* Table S1. Putative oncoPPIs for pan-cancer and individual cancer types.
* Table S2. Landscape of pharmacogenomics predicted by PPI disruptive mutations in cancer cell lines.
* Table S3. The yeast-two hybrid (Y2H) assay for 23 selected missense mutations across 13 mdPPIs.
